In Silico Drug Repurposing of FDA-Approved Drugs Highlighting Promacta as a Potential Inhibitor of H7N9 Influenza Virus

Influenza virus infections continue to be a significant and recurrent public health problem. Although vaccine efficacy varies, regular immunisation is the most effective method for suppressing the influenza virus. Antiviral drugs are available for influenza, although two of the four FDA-approved antiviral treatments have resulted in significant drug resistance. Therefore, new treatments are being sought to reduce the burden of flu-related illness. The time-consuming development of treatments for new and re-emerging diseases such as influenza and the high failure rate are increasing concerns. In this context, we used an in silico-based drug repurposing method to repurpose FDA-approved drugs as potential therapies against the H7N9 virus. To find potential inhibitors, a total of 2568 drugs were screened. Promacta, tucatinib, and lurasidone were identified as promising hits in the DrugBank database. According to the calculations of MM-GBSA, tucatinib (−54.11 kcal/mol) and Promacta (−56.20 kcal/mol) occupied the active site of neuraminidase with a higher binding affinity than the standard drug peramivir (−49.09 kcal/mol). Molecular dynamics (MD) simulation studies showed that the C-α atom backbones of the complexes of tucatinib and Promacta neuraminidase were stable throughout the simulation period. According to ADME analysis, the hit compounds have a high gastrointestinal absorption (GI) and do not exhibit properties that allow them to cross the blood–brain barrier (BBB). According to the in silico toxicity prediction, Promacta is not cardiotoxic, while lurasidone and tucatinib show only weak inhibition. Therefore, we propose to test these compounds experimentally against the influenza H7N9 virus. The investigation and validation of these potential H7N9 inhibitors would be beneficial in order to bring these compounds into clinical settings.     

Electrochemical Immunoassay for Tumor Marker CA19-9 Detection Based on Self-Assembled Monolayer

A CA19-9 electrochemical immunosensor was constructed using a hybrid self-assembled membrane modified with a gold electrode and applied to detect real samples. Hybrid self-assembled membranes were selected for electrode modification and used to detect antigens. First, the pretreated working electrodes were placed in a 3-mercaptopropionic acid (MPA)/β-mercaptoethanol (ME) mixture for 24 h for self-assembly. The electrodes were then placed in an EDC/NHS mixture for 1 h. Layer modification was performed by stepwise dropwise addition of CA19-9 antibody, BSA, and antigen. Differential pulse voltammetry was used to characterize this immunosensor preparation process. The assembled electrochemical immunosensor enables linear detection in the concentration range of 0.05–500 U/mL of CA19-9, and the detection limit was calculated as 0.01 U/mL. The results of the specificity measurement test showed that the signal change of the interfering substance was much lower than the response value of the detected antigen, indicating that the sensor has good specificity and strong anti-interference ability. The repeatability test results showed that the relative standard deviations were less than 5%, showing good accuracy and precision. The CA19-9 electrochemical immunosensor was used for the actual sample detection, and the experimental results of the standard serum addition method showed that the RSD values of the test concentrations were all less than 10%. The recoveries were 102.4–115.0%, indicating that the assay has high precision, good accuracy, and high potential application value.     

Prototropy,Intramolecular Interactions,Electron Delocalization,and Physicochemical Properties of 1,8-dihydroxy-9-anthrone—DFT-D3 Study of Substituent Effects

1,8-dihydroxy-9-anthrone are tricyclic compounds with a ketone group in the middle ring and two hydroxyl groups substituted in the side-aromatic rings what results in formation of two intramolecular hydrogen bonds in which the oxygen atom from the ketone group is the proton acceptor. 1,8-dihydroxy-9-anthrones in which intramolecular proton transfer between C10 and CO in the middle ring occurs, can exist in a tautomeric keto-enol equilibrium. For anthralin, the most important representative of this group, this equilibrium has been studied previously, but it has not been studied for its derivatives. Substituents in the middle ring change the geometry of 1,8-dihydroxy-9-anthrones so they are also expected to affect the keto-enol equilibrium. It is also important to study the effect of intramolecular hydrogen bonds on the structure of both tautomeric forms. It was found that the nature of the substituent in the middle ring could affect the antioxidant properties of the investigated compound.     

硫化钴改性石墨炔构建S型异质结高效光催化产氢

石墨炔(GDY,g-CnH2n-2)作为一种新型的由sp和sp2杂化的碳原子构成的二维碳材料,因其独特的纳米级孔隙、二维层状共轭骨架结构及半导体性质等特性,使之在能源、电化学、光催化、光学、电子学等诸多领域具有显著优势.它作为一种具有良好的层状结构的新型碳材料,其可调节的电子结构弥补了石墨烯无明显带隙的缺点,有望在光催...     

K9玻璃在脉冲CO2激光作用下的热应力分析

根据已建立的理论模型,计算得到了K9玻璃受脉冲CO2激光辐照时产生的热应力分布,研究了热应力的时间特征,在分析样品尺寸对损伤结果影响的基础上,提出了K9玻璃抗激光损伤的最佳半径。结果表明：K9玻璃产生的热应力损伤主要由环向应力控制,热应力以热冲击波的形式在样品内传播,大小随时间变化而来回振荡,且激光脉冲结束后比激光作用时间内产生的热应力要大。这说明若样品在激光加热期间产生的热应力不足以造成材料破坏,则有可能会在其后的冷却过程中产生更大的热应力,材料将会在冷却过程中发生破裂。根据样品参数对损伤结果的影响,进一步验证了K9玻璃抗激光损伤最佳半径的通用性。     

Theoretical Investigating Mechanisms of Drug-Resistance Generated by Mutation-Induced Changes in Influenza Viruses

Influenza A (A/H\begin{document}$ x $\end{document}N\begin{document}$ y $\end{document}) is a significant public health concern due to its high infectiousness and mortality. Neuraminidase, which interacts with sialic acid (SIA) in host cells, has become an essential target since its highly conserved catalytic center structure, while resistance mutations have already generated. Here, a detailed investigation of the drug resistance mechanism caused by mutations was performed for subtype N9 (A/H7N9). Molecular dynamics simulation and alanine-scanning-interaction-entropy method (ASIE) were used to explore the critical differences between N9 and Zanamivir (ZMR) before and after R294K mutation. The results showed that the mutation caused the hydrogen bond between Arg294 and ZMR to break, then the hydrogen bonding network was disrupted, leading to weakened binding ability and resistance. While in wild type (A/H7N9\begin{document}$ ^{ \rm{WT}} $\end{document}), this hydrogen bond was initially stable. Meanwhile, N9 derived from A/H11N9 was obtained as an R292K mutation. Then the relative binding free energy of N9 with five inhibitors (SIA, DAN, ZMR, G28, and G39) was predicted, basically consistent with experimental values, indicating that the calculated results were reliable by ASIE. In addition, Arg292 and Tyr406 were hot spots in the A/H11N9\begin{document}$ ^{ \rm{WT}} $\end{document}-drugs. However, Lys292 was not observed as a favorable contributing residue in A/H11N9\begin{document}$ ^{ \rm{R292K}} $\end{document}, which may promote resistance. In comparison, Tyr406 remained the hotspot feature when SIA, ZMR, and G28 binding to A/H11N9\begin{document}$ ^{ \rm{R292K}} $\end{document}. Combining the two groups, we speculate that the resistance was mainly caused by the disruption of the hydrogen bonding network and the transformation of hotspots. This study could guide novel drug delivery of drug-resistant mutations in the treatment of A/H\begin{document}$ x $\end{document}N9.     

移动通信终端多媒体系统设计

采用中星微VC0858在CDMA移动通信终端开发平台上实现了多媒体系统,详细介绍了硬件结构和软件系统的设计.测试结果证明该方案符合移动通信终端实际使用要求.     

一种ZigBee硬件平台的设计与实现

选择MC9S08GB60和MC13192构建了一种实现ZigBee的硬件系统框架,并在此基础上阐述了电源电路、MC13192与MC9S08GB60接口电路和MC13192射频模块的详细设计:文章的最后介绍了硬件测试过程.     

比久农药中游离偏二甲肼的高效液相色谱快速测定

建立了用甲醛衍生测定农药比久样品中微量的偏二甲肼的方法。采用甲醛与偏二甲肼柱前衍生,在室温、中性溶液中反应10 min,生成确定量的有较强紫外吸收的偏二甲腙,不须富集可直接用HPLC法测定偏二甲肼。研究了甲醛与偏二甲肼的反应条件及产物的光谱特征,测得衍生物的最大吸收波长λmax=237 nm和表观摩尔吸光系数ε=3.6×103(L.mol-1.cm-1),选定ZorbaxODS色谱柱,V(磷酸盐缓冲溶液,pH 7)∶V(甲醇)=94∶6为流动相,检测波长为237 nm。结果表明:在0.56~960μg/mL范围内回归方程为:A=0.4677ρ-0.2790,R2=0.9998,检出限为1.3μg/g,回收率为97.5%~103.4%,相对标准偏差为0.9%~1.8%。